FSD Pharma- Cannabis to Help Central Nervous System Disorders?

From Medical Marijuana to Pharmaceuticals

FSD Pharma wanted someone to help them transform from a medical marijuana company. And that’s what they brought me in to do. What we see is the medical marijuana business complementing the pharmaceutical endeavors. But the pharmaceutical part of the business will go its own way.

The type of disorders we’re looking are really CNS in particular. I can see how successful we are going to be. We’re just going to build and build and build on that.” – Rupert Haynes, CEO of FSD Pharma

This Pharma is a publicly traded company on the Canadian Securities Exchange. It is under the symbol HUGE.

The Company, through its wholly-owned subsidiary FV Pharma Inc., holds an ACMPR license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations.

HUGE, made history on its first day of trading on the Canadian Securities Exchange. It broke the all-time record for volume traded, making the company the largest volume traded in a single first day of trading.

It then went on to break the all-time record for weekly volume traded, monthly volume traded and yearly volume traded. HUGE broke the yearly volume traded record in just less than 2 months. And traded over a Billion shares in less than 2 months.

For more information on FSD Pharma (HUGE:CSE) please fill out the form below.

Request Investor Kit

Name*

Email*

*Required.